ImmuneOncia Therapeutics Revenue

Pharmaceutical Manufacturing • 마곡중앙로 172, Genexin-ProGen Bio Innovation Park, Korea, Republic of • 11-20 Employees

ImmuneOncia Therapeutics revenue & valuation

Annual revenue	$1,454,435
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,700,000
Total funding	$20,600,000

Key Contacts at ImmuneOncia Therapeutics

Jaemyoung Shim

Director, Business Planning

Heung Tae Kim

Chief Executive Officer

Company overview

Headquarters	마곡중앙로 172, Genexin-ProGen Bio Innovation Park, 6층, 서울특별시, 강서구 07789, KR
Phone number	+82313068186
Website	immuneoncia.com
NAICS	3254
Keywords	Oncology, Biopharmaceutical, Immuno-Oncology
Founded	2016
Employees	11-20
Socials

ImmuneOncia Therapeutics Email Formats

ImmuneOncia Therapeutics uses 1 email format. The most common is {last name}{first initial} (e.g., doej@immuneoncia.com), used 100% of the time.

Format	Example	Percentage
{last name}{first initial}	doej@immuneoncia.com	100%

About ImmuneOncia Therapeutics

ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan and Sorrento, ImmuneOncia will leverage both companies’ expertise in drug development and antibody engineering. Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide. ImmuneOncia’s portfolio includes diverse immune checkpoint antibodies; the lead antibody IMC-001 Phase I study was completed in Feb 2019 and its Phase 2 study is being prepared. ImmuneOncia is also developing several antibodies targeting novel immune-checkpoints.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

Entry

C-Suite

Employees by Department

ImmuneOncia Therapeutics has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore ImmuneOncia Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-17	1	$20,600,000

Funding Insights

$20,600,000

Total funding amount

$20,600,000

Most recent funding amount

Number of funding rounds

ImmuneOncia Therapeutics Tech Stack

Discover the technologies and tools that power ImmuneOncia Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Hosted Libraries

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Windows Server

Operating systems

PHP

Programming languages

Open Graph

Miscellaneous

Font Awesome

Font scripts

GSAP

JavaScript frameworks

WordPress

Blogs

IIS

Web servers

jQuery Migrate

JavaScript libraries

Bootstrap

UI frameworks

Frequently asked questions

ImmuneOncia Therapeutics is located in 마곡중앙로 172, Genexin-ProGen Bio Innovation Park, KR.

You can reach ImmuneOncia Therapeutics at +82313068186.

ImmuneOncia Therapeutics generates an estimated annual revenue of $1,454,435. This revenue figure reflects the company's market position and business performance in its industry.

ImmuneOncia Therapeutics has an estimated valuation of $4,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ImmuneOncia Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

ImmuneOncia Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ImmuneOncia Therapeutics has raised a total of $20,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ImmuneOncia Therapeutics

Jaemyoung Shim

Director, Business Planning

Heung Tae Kim

Chief Executive Officer

4.8

40,000 users